Industries worldwide are grappling with the increasing complexity of data generated by advanced sensors and IoT devices. The demand for real-time, high-precision analysis of non-stationary signals is escalating, driven by the need for proactive anomaly detection in manufacturing, enhanced diagnostic capabilities in healthcare, and stringent quality control in process industries. This technology directly addresses these challenges by providing a robust, model-free solution that reduces reliance on expert interpretation and accelerates data-driven decision-making across critical sectors.
Accurately quantifies time-varying frequency components from complex signals.
Enables detailed analysis from a single signal channel, simplifying data acquisition.
Delivers high-precision, model-free analysis for diverse non-stationary signals.
This patent protects a signal waveform analysis system and program capable of quantitatively extracting frequency components from complex, time-varying signals using wavelet analysis. With 8 claims, the patent demonstrates robust scope, having overcome two office actions, suggesting strong validity and low invalidation risk. Its limited prior art references underscore its high originality and market technical advantage.
This patent primarily covers the core wavelet analysis algorithm and system. White space exists in developing specialized sensor hardware for data acquisition, integrating the analysis output with advanced AI/ML models for autonomous decision-making, or creating novel user interfaces for data visualization and interpretation.
Introducing this technology into medical diagnostics could reduce complex biosignal analysis time by an average of 30%. For a hospital performing approximately 2000 diagnoses annually, shortening diagnosis time per case (e.g., from 10 minutes to 7 minutes) could increase the number of diagnoses per physician by about 600 cases annually. Assuming an annual physician salary of ~$100K (AI est.), a 30% improvement in diagnostic efficiency corresponds to ~$30K/year in cost savings (AI est.). Additionally, factoring in increased equipment utilization and reduced re-examination costs from lower misdiagnosis rates, an overall economic impact of ~$1.0M annually is anticipated (AI est.).
X: Analysis Accuracy and Real-time Capability
Y: Deployment Cost Efficiency